Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
The complement system plays a paradoxical role in the development and expression of autoimmunity in humans. The activation of complement in systemic lupus erythematosus (SLE) contributes to tissue injury. In contrast, inherited deficiency of classical pathway components, particularly C1q (ref. 1), is powerfully associated with the development of SLE. This leads to the hypothesis that a physiological action of the early part of the classical pathway protects against the development of SLE (ref. 2) and implies that C1q may play a key role in this respect. C1q-deficient (C1qa-/-) mice were generated by gene targeting and monitored for eight months. C1qa-/- mice had increased mortality and higher titres of autoantibodies, compared with strain-matched controls. Of the C1qa-/- mice, 25% had glomerulonephritis with immune deposits and multiple apoptotic cell bodies. Among mice without glomerulonephritis, there were significantly greater numbers of glomerular apoptotic bodies in C1q-deficient mice compared with controls. The phenotype associated with C1q deficiency was modified by background genes. These findings are compatible with the hypothesis that C1q deficiency causes autoimmunity by impairment of the clearance of apoptotic cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Casciola-Rosen, L. A., Anhalt, G., & Rosen, A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1317 · Cited by 1,717
Korb, L. C., & Ahearn, J. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.10.4525 · Cited by 657
Casciola-Rosen, L., Rosen, A., Petri, M., & Schlissel, M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1624 · Cited by 482
Baker, A. J., Mooney, A., Hughes, J., Lombardi, D., Johnson, R. J., & Savill, J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117565 · Cited by 404
LeFeber, W. P., Norris, D. A., Ryan, S. R., Huff, J. C., Lee, L. A., Kubo, M., Boyce, S. T., Kotzin, B. L., & Weston, W. L. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111569 · Cited by 335
Complement deficiency and disease
Morgan, B. P., & Walport, M. J. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90003-c · Cited by 302
Self-citationNovel packages of viral and self-antigens are generated during apoptosis.
Rosen, A., Casciola-Rosen, L., & Ahearn, J. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.4.1557 · Cited by 246
Hereditary C1q deficiency and systemic lupus erythematosus
(1994) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068955 · Cited by 207
Self-citationGolan, T. D., Elkon, K. B., Gharavi, A. E., & Krueger, J. G. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115922 · Cited by 165
Subnucleosome structures as substrates in enzyme-linked immunosorbent assays
Burlingame, R. W., & Rubin, R. L. (1990) · Journal of Immunological Methods · doi:10.1016/0022-1759(90)90380-e · Cited by 124
Cited by
Items 501–600 of 1,000
Requirement of dying cells and environmental adjuvants for the induction of autoimmunity
Bondanza, A., Zimmermann, V. S., DellʼAntonio, G., Cin, E. D., Balestrieri, G., Tincani, A., Amoura, Z., Pietté, J. C., Sabbadini, M. G., Rovere, P. Q., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20187 · Cited by 73
Pham, C. T. N., Mitchell, L. M., Huang, J. L., Lubniewski, C. M., Schall, O. F., Killgore, J. K., Pan, D., Wickline, S. A., Lanza, G. M., & Hourcade, D. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.180760 · Cited by 72
Murata, K., Fox-Talbot, K., Qian, Z., Takahashi, K., Stahl, G. L., Baldwin, W. M., & Wasowska, B. A. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.01971.x · Cited by 76
Teh, B. K., Yeo, J. G., Lai, M. C., & Lu, J. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.02.006 · Cited by 76
Complement C1q regulates LPS‐induced cytokine production in bone marrow‐derived dendritic cells
Yamada, M., Oritani, K., Kaisho, T., Ishikawa, J., Yoshida, H., Takahashi, I., Kawamoto, S., Ishida, N., Ujiie, H., Masaie, H., et al. (2004) · European Journal of Immunology · doi:10.1002/eji.200324026 · Cited by 68
Self-citationAllograft tolerance induced by donor apoptotic lymphocytes requires phagocytosis in the recipient
Sun, E., Gao, Y., Chen, J., Roberts, A. I., Wang, X., Chen, Z., & Shi, Y. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401500 · Cited by 72
“monocyte/macrophage phagocytosis of apoptotic cells and display increased numbers of apoptotic cells in the kidneys, with nephritis-like changes.(27) Finally, in diabetic BB rats or NOD mice, increased numbers of apoptotic islet b-cells are found to be accompanied by macrophage abnormalities, including decreased cell…”
Apoptosis and systemic lupus erythematosus
Sheriff, A., Gaipl, U. S., Voll, R. E., Kalden, J. R., & i, M. H. (2004) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2004.04.006 · Cited by 77
The Role of the Macrophage in Apoptosis: Hunter, Gatherer, and Regulator
Geske, F. J., Monks, J., Lehman, L. A., & Fadok, V. A. (2002) · International Journal of Hematology · doi:10.1007/bf02982714 · Cited by 80
Cell death: a trigger of autoimmunity?
Rodenburg, R. J., Raats, J. M. H., Pruijn, G. J. M., & VENROOIJ, W. J. V. (2000) · BioEssays · doi:10.1002/1521-1878(200007)22:7<627::aid-bies5>3.0.co;2-k · Cited by 86
MFG-E8-Dependent Clearance of Apoptotic Cells, and Autoimmunity Caused by Its Failure
Hanayama, R., Miyasaka, K., Nakaya, M., & Nagata, S. (2005) · Current Directions in Autoimmunity · doi:10.1159/000090780 · Cited by 69
Apaf-1-independent programmed cell death in mouse development
Nagasaka, A., Kawane, K., Yoshida, H., & Nagata, S. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.186 · Cited by 73
“It will be interesting to study the engulfment of necrotic cells by crossing the Apaf-1 / mice with mice deficient in the engulfment of apoptotic or necrotic cells.(44,45)”
BackgroundChen, G., Tan, C. S., Teh, B. K., & Lu, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.286427 · Cited by 71
Amarilyo, G., Verbovetski, I., Atallah, M., Grau, A., Wiser, G., Gil, O., Ben‐Neriah, Y., & Mevorach, D. (2010) · European Journal of Immunology · doi:10.1002/eji.200838951 · Cited by 67
Martens, H. A., Zuurman, M. W., de Lange, A. H. M., Nolte, I. M., van der Steege, G., Navis, G. J., Kallenberg, C. G. M., Seelen, M., & Bijl, M. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.085688 · Cited by 71
Benhnia, M. R., McCausland, M. M., Laudenslager, J., Granger, S. W., Rickert, S., Koriazova, L. K., Tahara, T., Kubo, R. T., Kato, S., & Crotty, S. (2009) · Journal of Virology · doi:10.1128/jvi.01593-09 · Cited by 73
“Human complement deficiencies are frequently associated with autoimmune diseases such as systematic lupus erythematosus, arthritis, and others (11, 12, 38, 64, 102, 103).”
BackgroundExtracellular DNA and autoimmune diseases
Lou, H., & Pickering, M. C. (2018) · Cellular and Molecular Immunology · doi:10.1038/cmi.2017.136 · Cited by 75
Neuronal localization of C1q in preclinical Alzheimer's disease
Fonseca, M. I., Kawas, C. H., Troncoso, J. C., & Tenner, A. J. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.09.004 · Cited by 71
“…the rapid clearance of apoptotic neurons or cellular debris while avoiding inflammation since C1q has been shown to bind to apoptotic cells (Botto et al., 1998; Korb and Ahearn, 1997) and enhance phagocytosis (Henson et al., 2001; Webster et al., 2000) without triggering proinflammatory…”
BackgroundChan, R. K., Ibrahim, S. I., Takahashi, K., Kwon, E., McCormack, M. C., Ezekowitz, A. B., Carroll, M. C., Moore, F. D., & Austen, W. G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.8080 · Cited by 70
“C1q-deficient mice lack the classical pathway but retain robust MBL and alternative pathways (10), whereas MBL-deficient mice have a robust classical and alternative pathway while lacking MBL (7, 12).”
BackgroundFraser, D. A., Arora, M., Bohlson, S. S., Lozano, E., & Tenner, A. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m605741200 · Cited by 65
Effects of Glucocorticoids on Apoptosis and Clearance of Apoptotic Cells
McColl, A., Michlewska, S., Dransfield, I., & Rossi, A. G. (2007) · The Scientific World JOURNAL · doi:10.1100/tsw.2007.224 · Cited by 79
Chen, J. Y., Wu, Y. L., Mok, M. Y., Wu, Y. J., Lintner, K. E., Wang, C., Chung, E. K., Yang, Y., Zhou, B., Wang, H., et al. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39589 · Cited by 73
Natural serum IgM maintains immunological homeostasis and prevents autoimmunity
Manson, J. J., Mauri, C., & Ehrenstein, M. R. (2004) · Springer Seminars in Immunopathology · doi:10.1007/s00281-004-0187-x · Cited by 70
“Absence of the first component of the classical pathway of complement results in glomerulonephritis in both mouse and humans, and this is thought to be due to the persistence of multiple apoptotic bodies [31].”
BackgroundA Role for the Cr2 Gene in Modifying Autoantibody Production in Systemic Lupus Erythematosus
Wu, X., Jiang, N., Deppong, C., Singh, J., Dolecki, G., Mao, D., Morel, L., & Molina, H. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.3.1587 · Cited by 71
Functional heterogeneity of alveolar macrophage population based on expression of CXCL2
Xu-Vanpala, S., Deerhake, M. E., Wheaton, J. D., Parker, M. E., Juvvadi, P. R., MacIver, N. J., Ciofani, M., & Shinohara, M. L. (2020) · Science Immunology · doi:10.1126/sciimmunol.aba7350 · Cited by 70
Autoantibody-mediated demyelination depends on complement activation but not activatory Fc-receptors
Urich, E., Gutcher, I., Prinz, M., & Becher, B. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607283103 · Cited by 67
Microvesicles in Autoimmune Diseases
Liu, M., Williams, K. J., & Werth, V. P. (2016) · Advances in clinical chemistry · doi:10.1016/bs.acc.2016.06.005 · Cited by 74
Phuan, P.-W., Zhang, H., Asavapanumas, N., Leviten, M., Rosenthal, A., Tradtrantip, L., & Verkman, A. S. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1128-3 · Cited by 69
“About 25 % of C1q knockout mice developed glomerulonephritis with immune deposits and multiple apoptotic cell bodies [5], with many apoptotic cells also seen in mice without glomerulonephritis, suggesting that C1q deficiency causes autoimmunity by impairing the clearance of apoptotic cells.”
Willis, D., Moore, A., & Willoughby, D. A. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200004)190:5<627::aid-path556>3.0.co;2-2 · Cited by 73
“However, it is interesting to note that C1q knockout animals develop a chronic in ̄ammatory lesion [21], suggesting an antiin ̄ammatory role for this component of the complement cascade, and display a similar pathology to that of the HO-1 knockout mice [22,23].”
ResultThe clearance of apoptotic cells by complement
Flierman, R., & Daha, M. R. (2007) · Immunobiology · doi:10.1016/j.imbio.2006.11.005 · Cited by 64
Seelen, M. A., van der Bijl, E. A., Trouw, L. A., Zuiverloon, T. C. M., Munoz, J. R., den Houten, F. C. F.-V., Schlagwein, N., Daha, M. R., Huizinga, T. W. J., & Roos, A. (2004) · British journal of rheumatology · doi:10.1093/rheumatology/keh417 · Cited by 71
“This association between C1q deficiency and systemic autoimmunity has been linked to a role for C1q in recognition and clearance of apoptotic material [3, 4 ]. Defective clearance and increased generation of apoptotic material has been demonstrated in patients with SLE [5].”
BackgroundWhat does complement do in Alzheimer’s disease? Old molecules with new insights
Shen, Y., Yang, L., & Li, R. (2013) · Translational Neurodegeneration · doi:10.1186/2047-9158-2-21 · Cited by 60
Rother, R. P., Mojcik, C. F., & McCroskery, E. W. (2004) · Lupus · doi:10.1191/0961203303lu1021oa · Cited by 67
Continual Low-Level Activation of the Classical Complement Pathway
Manderson, A. P., Pickering, M. C., Botto, M., Walport, M. J., & Parish, C. R. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.747 · Cited by 67
“C1q-knockout (C1qa / ) (20), C4 / (21, 22), factor B knockout (Bf / ), and H2-Bf,C2 / mice (23) were all generated as previously described.”
Self-citationLinks between complement deficiency and apoptosis.
Botto, M. (2001) · Arthritis Research · doi:10.1186/ar301 · Cited by 72
“These mice, on the hybrid genetic background (129 × C57BL/6), developed significant titres of antinuclear antibodies and proliferative glomerulonephritis characterised by an increased number of uncleared apoptotic bodies [24], independently of C3 activation [25].”
BackgroundSelf-citationIntracellular Nucleic Acid Sensors and Autoimmunity
Theofilopoulos, A. N., Kono, D. H., Beutler, B., & Baccalà, R. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2011.0092 · Cited by 74
Whole Exome Sequencing in Early-onset Systemic Lupus Erythematosus
Batu, E. D., Koşukçu, C., Taşkıran, E. Z., Şahin, S., Akman, S., Sözeri, B., Ünsal, E., Bilginer, Y., Kasapçopur, Ö., Alikaşifoğlu, M., et al. (2018) · The Journal of Rheumatology · doi:10.3899/jrheum.171358 · Cited by 66
Whole exome sequencing in childhood-onset lupus frequently detects single gene etiologies
Tirosh, I., Spielman, S., Barel, O., Ram, R., Stauber, T., Paret, G., Rubinsthein, M., Pessach, I. M., Gerstein, M., Anikster, Y., et al. (2019) · Pediatric Rheumatology · doi:10.1186/s12969-019-0349-y · Cited by 66
Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus
Marion, T. N., & Postlethwaite, A. E. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0440-x · Cited by 73
Enhancement of neutralizing activity of influenza virus-specific antibodies by serum components
Mozdzanowska, K., Feng, J., Eid, M., Zharikova, D., & Gerhard, W. (2006) · Virology · doi:10.1016/j.virol.2006.05.008 · Cited by 66
Circulating C1q levels in health and disease, more than just a biomarker
van de Bovenkamp, F. S., Dijkstra, D. J., van Kooten, C., Gelderman, K. A., & Trouw, L. A. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2021.10.010 · Cited by 68
“This would result in exposure of intracellular molecules, eliciting an immune response against these (self) molecules (Botto et al., 1998).”
BackgroundSurfactant Protein A Regulates Complement Activation
Watford, W. T., Wright, J. R., Hester, C. G., Jiang, H., & Frank, M. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6593 · Cited by 65
“was shown to enhance the clearance of apoptotic cells (17), a function previously described for C1q (18, 19).”
BackgroundRen, G., Su, J., Zhao, X., Zhang, L., Zhang, J., Roberts, A. I., Zhang, H., Das, G., & Shi, Y. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3277 · Cited by 64
Gillmore, J. D., Hutchinson, W. L., Herbert, J., Bybee, A., Mitchell, D. A., Hasserjian, R. P., Yamamura, K., Suzuki, M., Sabin, C. A., & Pepys, M. B. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01860.x · Cited by 63
A Regulatory Role for Complement in Innate Immunity and Autoimmunity
Nauta, A. J., Roos, A., & Daha, M. R. (2004) · International Archives of Allergy and Immunology · doi:10.1159/000079261 · Cited by 77
“Similarly, in mice with deficiencies in C1q, multiple apoptotic bodies are present in the kidney associated with the spontaneous development of autoantibodies and glomerulonephritis [”
BackgroundAN APPETITE FOR APOPTOTIC CELLS? CONTROVERSIES AND CHALLENGES
Giles, K. M., Hart, S. P., Haslett, C., Rossi, A. G., & Dransfield, I. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.01805.x · Cited by 64
“Recent data have also suggested a role for elements of humoral immunity, speci®cally, complement components C1q (Botto et al, 1998) and C3bi (Mevorach et al, 1998).”
BackgroundLawson, B. R., Baccala, R., Song, J., Croft, M., Kono, D. H., & Theofilopoulos, A. N. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031685 · Cited by 65
McGaha, T. L., & Karlsson, M. C. I. (2015) · Immunological Reviews · doi:10.1111/imr.12382 · Cited by 69
“The importance of complementmediated clearance is best illustrated by the fact that over 90% of patients with C1q deficiency develop SLE, and C1q-deficient mice develop spontaneous lupus-like disease (15, 57).”
BackgroundKunz, N., & Kemper, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.629986 · Cited by 67
Hemmi, H., Idoyaga, J., Suda, K., Suda, N., Kennedy, K., Noda, M., Aderem, A., & Steinman, R. M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1278 · Cited by 62
Anderson, H. A., Englert, R. P., Gürsel, İ., & Shacter, E. B. (2002) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401013 · Cited by 66
Accumulation of plasma nucleosomes upon treatment with anti‐tumour necrosis factor‐α antibodies
D׳Auria, F., Rovere, P. Q., Giazzon, M., Ajello, P., Baldissera, E. M., Manfredi, A. A., & Sabbadini, M. G. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2003.01298.x · Cited by 72
Engulfment of apoptotic cells by microvascular endothelial cells induces proinflammatory responses
Kirsch, T., Woywodt, A., Beese, M., Wyss, K., Park, J.-K., Erdbrüegger, U., Hertel, B., Haller, H. G., & Haubitz, M. (2006) · Blood · doi:10.1182/blood-2006-06-026187 · Cited by 66
“This concept of aquired autoimmunity has also been confirmed in several animal models that showed disturbed engulfment of apoptotic cells.(7-10) Vascular endothelial cells serve as a crucial barrier between tissues and the circulation.”
BackgroundThe Role of Complement in Cryoglobulin-Induced Immune Complex Glomerulonephritis
Trendelenburg, M., Fossati‐Jimack, L., Cortés-Hernández, J., Turnberg, D., Lewis, M., Izui, S., Cook, H. T., & Botto, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6909 · Cited by 64
Self-citationDifferential regulation of Abeta42-induced neuronal C1q synthesis and microglial activation.
Fan, R., & Tenner, A. J. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-1 · Cited by 63
“Being able to distinguish in the slice system C1q expression (which has been shown to facilitate phagocytosis of apoptotic cells in other systems [24]) from microglial activation suggests a plausible approach to reach that goal in vivo.”
Sharif, O., Gawish, R., Warszawska, J. M., Martins, R., Lakovits, K., Hladik, A., Doninger, B., Brunner, J., Korosec, A., Schwarzenbacher, R. E., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004167 · Cited by 60
“In some experiments, bacteria were pre-opsonised with either 10% pooled WT mouse serum, C1qa serum [47] or 10% Type III capsular antibody (Statens Serum Institute, Denmark) in RPMI for 30 min before addition to the cells.”
Ratelade, J., & Verkman, A. S. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.06.003 · Cited by 62
“Phenotypes of C1q-deficient mice (Botto et al., 1998), such as development of glomerulonephritis, are due to other functions of C1q such as removal of apoptotic cells or clearance of immune complexes rather than defective classical complement cytotoxicity (Nayak et al.”
BackgroundBerg, A., Zelano, J., Stephan, A. H., Thams, S., Barres, B. A., Pekny, M., Pekna, M., & Cullheim, S. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.06.008 · Cited by 63
Yaseen, S., Demopulos, G., Dudler, T., Yabuki, M., Wood, C. L., Cummings, W. J., Tjoelker, L. W., Fujita, T., Sacks, S. H., Garred, P., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201601306r · Cited by 70
“Mouse sera were prepared from pooled C57BL/6 wild-type mouse blood or C57BL/6 mice with targeted deficiency of complement componentsMASP-1 and -3 (23),MASP-2 (29), C1q (46), C3 (47), and C4 (48).”
MethodGregory, C. D., & Paterson, M. (2018) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2017.0003 · Cited by 57
C1q-binding proteins and C1q receptors
Nicholson-Weller, A., & Klickstein, L. B. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)80008-9 · Cited by 63
Apoptosis and macrophage clearance of neutrophils: regulation by reactive oxygen species
Fadeel, B., & Kagan, V. E. (2003) · Redox Report · doi:10.1179/135100003225001511 · Cited by 69
Lack of SIGIRR/TIR8 aggravates hydrocarbon oil‐induced lupus nephritis
Lech, M., Skuginna, V., Kulkarni, O. P., Gong, J., Wei, T., Stark, R. W., Garlanda, C., Mantovani, A., & Anders, H. (2010) · The Journal of Pathology · doi:10.1002/path.2678 · Cited by 65
Tedder, T. F., Baras, A., & Xiu, Y. (2006) · Springer Seminars in Immunopathology · doi:10.1007/s00281-006-0057-9 · Cited by 67
“Furthermore, CD20 mAbs effectively clear blood and spleen B cells in C3- and C4-deficient [122] and C1qdeficient [9] mice.”
BackgroundFundamental roles of the innate-like repertoire of natural antibodies in immune homeostasis
Vas, J., Grönwall, C., & Silverman, G. J. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00004 · Cited by 62
“…suggested by studies with targeted deficiencies in C1q, MBL, or secreted IgM, which each have impaired control of inflammatory responses, and in some cases are predisposed to the development of autoimmune disease (Botto et al., 1998; Boes et al., 2000; Ehrenstein et al., 2000; Stuart et al., 2005).”
BackgroundStokol, T., O’Donnell, P., Xiao, L., Knight, S., Stavrakis, G., Botto, M., von Andrian, U. H., & Mayadas, T. N. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040501 · Cited by 71
Self-citationCarlucci, F., Cortés-Hernández, J., Fossati‐Jimack, L., Bygrave, A. E., Walport, M. J., Vyse, T. J., Cook, H. T., & Botto, M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2352 · Cited by 62
Self-citationPlasma Membrane Alterations During Apoptosis: Role in Corpse Clearance
Fadeel, B. (2004) · Antioxidants and Redox Signaling · doi:10.1089/152308604322899332 · Cited by 70
Trouw, L. A., Seelen, M. A., Duijs, J. M. G. J., Benediktsson, H., van Kooten, C., & Daha, M. R. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02108.x · Cited by 67
Complement and the kidney: What the nephrologist needs to know in 2006?
Berger, S. P., Roos, A., & Daha, M. R. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi166 · Cited by 61
“The disruption of both the C1q or the C4 gene in mice with a 129 C57BL/6 genetic background leads to the spontaneous development of glomerulonephritis as well as to the production of autoantibodies and accumulation of apoptotic cells [7,8].”
The long pentraxin PTX 3: A prototypical sensor of tissue injury and a regulator of homeostasis
Erreni, M., Manfredi, A. A., Garlanda, C., Mantovani, A., & Rovere, P. Q. (2017) · Immunological Reviews · doi:10.1111/imr.12570 · Cited by 63
Navratil, J. S., Korb, L. C., & Ahearn, J. M. (1999) · Immunopharmacology · doi:10.1016/s0162-3109(99)00018-1 · Cited by 61
Detection and characterization of soluble CD93 released during inflammation
Greenlee‐Wacker, M. C., Sullivan, S. A., & Bohlson, S. S. (2009) · Inflammation Research · doi:10.1007/s00011-009-0064-0 · Cited by 65
“removal of apoptotic cells such as C1q and other complement components [25, 29], enhanced engulfment of apoptotic cells was observed at all three time points com-”
Lupus Susceptibility Genes on Human Chromosome 1
Tsao, B. R. (2000) · International Reviews of Immunology · doi:10.3109/08830180009055502 · Cited by 61
Palaniyar, N., Clark, H. W., Nadesalingam, J., Shih, M. J., Hawgood, S. B., & Reid, K. B. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.7352 · Cited by 66
“E-mail address: nades.palaniyar@sickkids.ca 3 Abbreviations used in this paper: SP-, surfactant-associated protein; AM, alveolar macrophage; ANA, anti-nuclear antibody; BAL, bronchoalveolar lavage; C1q, complement component 1q; CRD, carbohydrate recognition domain; MBL, mannosebinding lectin; SLE, systemic lupus eryth…”
BackgroundInfluentialKuhn, A., Wenzel, J., & Bijl, M. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0550-0 · Cited by 65
Surviving Mousepox Infection Requires the Complement System
Moulton, E. A., Atkinson, J. P., & Buller, R. M. L. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000249 · Cited by 63
“Mice The following strains on a C57BL/6 background were acquired: C32/2 [56,75] and FB2/2 [76,77] from H. Molina, Washington University Medical School; C42/2 [78] from M. Carroll, Harvard Medical School; B cell-deficient mMT [79] from H. W. Virgin, Washington University Medical School; C1q2/2 [80] from M. Botto, Imper…”
BackgroundGeneration of a Complement-Independent Bactericidal IgM against a Relapsing Fever Borrelia
Connolly, S., Thanassi, D. G., & Benach, J. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.1191 · Cited by 59
“C1q-deficient (C1qa / ) mice were a gift from M. Botto (Imperial College, London, U.K.) and supplied by G. Stahl (Harvard Medical School, Cambridge, MA) (21).”
Huck, S., Deveaud, E., Namane, A., & Zouali, M. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.11.1415 · Cited by 59
“Since it was recently recognized that in lupus the autoantibody process is caused by impairment of the clearance of apoptotic cells ( 2 ), we would like to propose that the accelerated apoptosis and the persistence of abnormally methylated and GC-rich nucleosomes released from apoptotic cells provide an autologous sti…”
BackgroundMouse Models of Human Autoimmune Diseases: Essential Tools That Require the Proper Controls
Morel, L. M. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020241 · Cited by 59
“…autoantibodies and mild antibody-related renal pathology, highly relevant to autoimmune diseases, especially SLE, has been reported independently in four mouse models using the (129 × B6) genetic background (Obara et al. 1979; Botto et al 1998; Bickerstaff et al. 1999; SantiagoRaber et al. 2001).”
Toll-like receptors and innate immune responses in systemic lupus erythematosus
Lafyatis, R., & Marshak‐Rothstein, A. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2321 · Cited by 60
Toll-Like Receptors and Activation of Autoreactive B Cells
Leadbetter, E. A., Rifkin, I. R., & Marshak‐Rothstein, A. (2002) · KARGER eBooks · doi:10.1159/000066858 · Cited by 63
Role of Complement and Other Innate Immune Mechanisms in the Removal of Apoptotic Cells
Ogden, C. A., & Elkon, K. B. (2005) · KARGER eBooks · doi:10.1159/000090776 · Cited by 59
Statin-Regulated Efferocytosis in Physiological and Pathological Conditions
Tajbakhsh, A., Hayat, S. M. G., Askari, H., Savardashtaki, A., Pirro, M., Johnston, T. P., & Sahebkar, A. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108282 · Cited by 63
Gingras, A. R., Girija, U. V., Keeble, A. H., Panchal, R., Mitchell, D. A., Moody, P. C. E., & Wallis, R. (2011) · Structure · doi:10.1016/j.str.2011.08.014 · Cited by 58
Association of a non-synonymous single-nucleotide polymorphism of DNASEI with SLE susceptibility
Bodaño, A., González, A., Ferreirós-Vidal, I., Balada, E., Ordi‐Ros, J., Carreira, P. E., Gómez-Reino, J. J., & Conde, C. (2006) · Rheumatology · doi:10.1093/rheumatology/kel019 · Cited by 58
“Other studies to identify candidate genes have revealed a role for histocompatibility antigens, complement components, low-affinity receptors for immunoglobulin G (IgG) [4] and genes involved in the clearance of apoptotic cells [5–11], among others.”
BackgroundByrne, J. C., Ní Gabhann, J., Stacey, K. B., Coffey, B. M., McCarthy, E., Thomas, W., & Jefferies, C. A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300057 · Cited by 56
“Interestingly, a strong association between C1q deficiency and SLE has been demonstrated, with loss of C1q leading to accumulation of apoptotic cells, enhanced inflammation, and production of autoantibodies (41, 42).”
BackgroundAutoantigens as Partners in Initiation and Propagation of Autoimmune Rheumatic Diseases
Rosen, A., & Casciola-Rosen, L. A. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112205 · Cited by 62
“Korb LC, Ahearn JM. 1997 C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: Complement deficiency and systemic lupus erythematosus revisited.”
BackgroundInfluentialNiewold, T. B. (2015) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000205 · Cited by 61
“One of the earliest discovered monogenic causes of lupus with a very high penetrance is C1Q deficiency [46].”
BackgroundProtein C anticoagulant activity in relation to anti-inflammatory and anti-apoptotic activities
Laurent, O. (2006) · Frontiers in bioscience · doi:10.2741/1977 · Cited by 64
“C1q binds specifically to the surface of blebs of apoptotic cells and stimulates the uptake of apoptotic cells by macrophages; accordingly, deficiency in C1q result in increased circulation apoptotic bodies consistent with a defect in clearance of apoptotic cells (123-125).”
BackgroundGiacomin, P., Gordon, D., Botto, M., Daha, M. R., Sanderson, S. D., Taylor, S. M., & Dent, L. A. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.05.029 · Cited by 58
Self-citationBuanec, H. L., Gougeon, M., Mathian, A., Lebon, P., Dupont, J., Peltre, G., Hémon, P., Schmid, M., Bizzini, B., Künding, T., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113301108 · Cited by 63
Defective Fc‐dependent processing of immune complexes in patients with systemic lupus erythematosus
Davies, K. A., Robson, M. G., Peters, A. M., Norsworthy, P. J., Nash, J. T., & Walport, M. J. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10189 · Cited by 58
Self-citationAutoantigens in systemic autoimmunity: critical partner in pathogenesis
Rosen, A., & Casciola-Rosen, L. A. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02102.x · Cited by 58
Santer, D. M., WIEDEMAN, A. E., Teal, T. H., Ghosh, P., & Elkon, K. B. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102797 · Cited by 110
“In vivo it is likely that the early classical complement proteins, C1q, C2, and C4, may act in a common pathway leading to the assembly of C3bi on apoptotic cells, which we, and others, previously showed is important for the clearance of dying cells (8, 9).”
Boackle, S. A. (2003) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(03)00084-2 · Cited by 57
Complement and systemic lupus erythematosus
Karp, D. R. (2005) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000172799.03379.86 · Cited by 57
Complement in Lupus Nephritis: The Good, the Bad, and the Unknown
Bao, L., & Quigg, R. J. (2007) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2006.09.009 · Cited by 62
Ferry, H., Jones, M., Vaux, D. J., Roberts, I. S. D., & Cornall, R. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030279 · Cited by 60
“In familial human SLE due to C1q deficiency, the primary defect lesion seems likely to be due to reduced phagocytic clearance of apoptotic or necrotic cells (25, 26).”
BackgroundMurine lupus genetics: lessons learned
Mohan, C. (2001) · Current Opinion in Rheumatology · doi:10.1097/00002281-200109000-00003 · Cited by 57
Complement C 4 maintains peripheral B ‐cell tolerance in a myeloid cell dependent manner
Chatterjee, P., Agyemang, A. F., Alimzhanov, M. B., Degn, S. E., Tsiftsoglou, S. A., Alicot, E. M., Jones, S. A., Ma, M., & Carroll, M. C. (2013) · European Journal of Immunology · doi:10.1002/eji.201343412 · Cited by 56
Metadata
- Authors
- Botto, M., Dell' Agnola, C., Bygrave, A. E., Thompson, E. M., Cook, H. T., Petry, F., Loos, M., Pandolfi, P. P., & Walport, M. J.
- Affiliations
- Imperial College London (GB)
- Institute of Medical Microbiology and Hygiene (DE)
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Walport, Mark J.
- Venue
- Nature Genetics
- Published
- 1998-05
- Volume
- 19
- Issue
- 1
- Pages
- 56-59
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2067217824
- Cited by
- 1,434
- References
- 21
- Citations by year
- 2026: 13 · 2025: 15 · 2024: 22 · 2023: 18 · 2022: 27 · 2021: 29 · 2020: 20 · 2019: 39 · 2018: 29 · 2017: 37 · 2016: 27 · 2015: 36 · 2014: 47 · 2013: 39 · 2012: 62
- FWCI
- 49.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Keywords
- C1q deficiency, glomerulonephritis, apoptotic bodies, systemic lupus erythematosus, classical complement pathway, autoimmunity, autoantibodies, efferocytosis, genetic background effects, immune deposits
- MeSH terms
- Animals, Antibodies, Antinuclear, Autoantigens, Crosses, Genetic, Glomerulonephritis, Homozygote, Kidney Glomerulus, Microscopy, Electron, Complement C1q, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.